The Venture Codex Logo

The Venture Codex

415 Capital

Widenmayerstraße 15, Munich, Bayern, 80538, Germany

Overview

Venture capital firm investing in breakthrough medical device technologies.

Founded

2018

Deals · 12mo

2

Links

WebsiteLinkedIn

Stage focus

Multi-stage

Geographic focus

France
Israel
Switzerland
United States

Sector focus

Health Care

Investment portfolio

13rounds
NAMEDATESIZE
ReEmerge
Sep 2026Participated
$37 MSeries A
Endovascular Engineering
Apr 2026Participated
$80 MSeries C
Supira Medical
Mar 2025Participated
$120 MSeries E
Endovascular Engineering
Feb 2025Led
$42 MSeries B
CorFlow Therapeutics AG
Sep 2024Participated
$49 MSeries B
R3 Vascular
May 2024Participated
$87 MSeries B
Supira Medical
Nov 2023Participated
$40 MSeries D
Tricares
Dec 2022Led
$54 MSeries C
Supira Medical
Feb 2022Participated
$30 MSeries C
Distalmotion
Jan 2022Participated
$90 MSeries E
Cardiac Success
Jun 2021Led
$5 MSeries A
Moray Medical
Apr 2021Led
$6 MSeed
ReEmerge
Sep 2026Participated
$37 MSeries A
Endovascular Engineering
Apr 2026Participated
$80 MSeries C
Supira Medical
Mar 2025Participated
$120 MSeries E
Endovascular Engineering
Feb 2025Led
$42 MSeries B
CorFlow Therapeutics AG
Sep 2024Participated
$49 MSeries B
R3 Vascular
May 2024Participated
$87 MSeries B
Supira Medical
Nov 2023Participated
$40 MSeries D
Tricares
Dec 2022Led
$54 MSeries C
Supira Medical
Feb 2022Participated
$30 MSeries C
Distalmotion
Jan 2022Participated
$90 MSeries E
Cardiac Success
Jun 2021Led
$5 MSeries A
Moray Medical
Apr 2021Led
$6 MSeed
13
Items
...
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

415 Capital: 13 funding rounds are recorded in the selected participation categories.All available history.
415 Capital: 13 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Seed10
Series A21
Series B12
Series C+15

Monthly Deal Activity

415 Capital: 13 deals are recorded across 73 months.All available history.
415 Capital: 13 deals are recorded across 73 months. All available history
MonthDeals
Oct '201
Nov '200
Dec '200
Jan '210
Feb '210
Mar '210
Apr '211
May '210
Jun '211
Jul '210
Aug '210
Sep '210
Oct '210
Nov '210
Dec '210
Jan '221
Feb '221
Mar '220
Apr '220
May '220
Jun '220
Jul '220
Aug '220
Sep '220
Oct '220
Nov '220
Dec '221
Jan '230
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '231
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '241
Jun '240
Jul '240
Aug '240
Sep '241
Oct '240
Nov '240
Dec '240
Jan '250
Feb '251
Mar '251
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '261
May '260
Jun '260
Jul '260
Aug '260
Sep '261
Oct '260

Sector Breakdown

415 Capital: Health & Life Sciences is the largest displayed sector by deal count (13 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

415 Capital: Health & Life Sciences is the largest displayed sector by deal count (13 deals). All available history
SectorDeals
Health & Life Sciences13
Manufacturing2
Hardware & Robotics1

Deal Size Distribution

415 Capital: 13 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

415 Capital: 13 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M2
$10M-$25M1
$25M-$50M5
$50M-$100M4
$100M-$250M1
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

415 Capital: United States has the largest recorded deal count among the displayed regions (9 deals).All available history.

Top 3 of 3 regions; European countries are grouped as Europe.

415 Capital: United States has the largest recorded deal count among the displayed regions (9 deals). All available history
RegionDeals
United States9
Europe3
Israel1
415 Capital: 20 co-investors are shown, with AMED Ventures sharing 3 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

415 Capital: 20 co-investors are shown, with AMED Ventures sharing 3 recorded deals. All available history
Co-investorShared deals
AMED Ventures3
Cormorant Asset Management3
M&L Investments3
PA MedTech3
Panakes Partners3
Sante Ventures3
The Capital Partnership3
Unorthodox Ventures3
S3 Ventures2
Wellington Partners2
Andera Partners1
Bayern Kapital1
BioMedPartners1
Broadview Ventures1
Cordis1
Credit Mutuel Innovation1
Deerfield Management1
Dendrion Ventures1
Gilde Healthcare1
Go Capital1

Investment Strategy

415 Capital: Led accounts for 38% and participating for 62% of round participation.All available history.
415 Capital: Led accounts for 38% and participating for 62% of round participation. All available history
CategoryDeals (count)Share (%)
Led538%
Participating862%
415 Capital: Single-lead accounts for 80% and co-led for 20% of lead dynamics.All available history.
415 Capital: Single-lead accounts for 80% and co-led for 20% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead480%
Co-led120%

Team

Azin Parhizgar, PhD

Senior Venture Partner

Frank Groenewegen

Managing Director

Frederik Groenewegen

Managing Director